NCT00937729终止不适用
Prospective Evaluation Among Patients Infected by HIV 1 in Virological Failure Owing to Lack of Compliance, of the Benefit in Terms of Compliance of an Optimised Antiretroviral Treatment Containing Enfuvirtide (Fuzeon) Associated With Two Active Molecules
University Hospital, Rouen1 个研究点 分布在 1 个国家目标入组 4 人开始时间: 2009年6月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 发起方
- 入组人数
- 4
- 试验地点
- 1
- 主要终点
- viral load compliance
研究概览
简要总结
In case of lack of compliance in HIV1 patients, the investigators hope to prove that enfuvirtide injection during almost 3 months, with nurse help at home and therapeutic education may contribute to obtain a good compliance more than 95% in these patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •virological failure, more than 18 years, prouved lack of compliance, with no sub-optimal treatment, in ambulatory status.
排除标准
- •hospitalization,HIV2 infection,pregnancy,preliminary treatment with enfuvirtide,chimiotherapy , opportunistic infection in progress
结局指标
主要结局
viral load compliance
时间窗: one year
次要结局
- statistical analysis of MOS HIV(one year)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide ResistanceHIV InfectionsNCT00187551University of California, San Francisco25
已完成
4 期
Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy in HIV Patients With Viral SuppressionHIV InfectionNCT01471821Juan A. Arnaiz250
已完成
不适用
Addition of Ezetimibe (Ezetrol®) to Ongoing Therapy With Rosuvastatin (Crestor®) in HIV Positive Patients Not Reaching Cholesterol TargetsHypercholesterolemiaHIV InfectionsNCT00908011University of British Columbia43
已完成
4 期
Comparison of Two Combinations in Antiretroviral Post-Exposure Prophylaxis for HIV-1: Tenofovir/Emtricitabine (Truvada ®) + Lopinavir/Ritonavir (Kaletra ®) vs Tenofovir/Emtricitabine/Cobicistat/Elvitegravir (Stribild ®). Prospective, Randomized, Open.HIVNCT02198443Fundacion Clinic per a la Recerca Biomédica160
已完成
不适用
RAL-eve Study: Raltegravir Substitution StudyHIV InfectionsNCT00523237Stanford University14